Alkem Labs (Alkem) has received closure inspection for Its Bioequivalence Facility at Taloja from the United Kingdom - The Medicines and Healthcare Products Regulatory Agency (UK-MHRA). The facility stands UK-MHRA compliant. The UK-MHRA had inspected the Bioequivalence Facility at Taloja from 14 to 18 March 2016 and had notified its observations in a report dated 30th March, 2016. The GCP Inspectorate has reviewed the corrective and a preventive action submitted by the company and has considered them acceptable.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets. With a portfolio of more than 700 brands In India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales. The company also has presence in more than 50 international markets, with the United Stated being its key focus market.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1814.30 |
Dr. Reddys Lab | 1350.85 |
Cipla | 1479.25 |
Lupin | 2175.30 |
Zydus Lifesciences | 975.55 |
View more.. |